GlassScriptPhysician profile
Carissa K Ramirez
NPI 1093100489
$1,226.01
in general payments reported to CMS, 2019-2025
19 companies · $309 in 2025
The $309 reported for 2025 was more than what 75% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $192 · 2023: $271 · 2024: $234 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $265.20 | 2022-2025 | Veozah |
| Abbvie INC. | $168.69 | 2021-2025 | |
| Shield Therapeutics INC | $110.54 | 2023-2024 | Accrufer |
| Avadel Cns Pharmaceuticals, LLC | $93.62 | 2025 | Lumryz |
| Exeltis, USA INC. | $85.91 | 2021-2025 | Slynd |
| Organon LLC | $82.65 | 2022-2025 | Nexplanon |
| Evofem Biosciences, INC. | $78.27 | 2021-2025 | Phexxi, Solosec, Phexx |
| Novo Nordisk INC | $58.41 | 2022-2024 | Wegovy |
| Pfizer INC. | $47.80 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $44.13 | 2025 | |
| Avanos Medical | $36.04 | 2021 | |
| Avion Pharmaceuticals | $23.13 | 2022 | |
| Myovant Sciences INC. | $22.91 | 2021 | |
| Agile Therapeutics, INC. | $21.20 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.97 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.37 | 2024 | Vumerity |
| Becton, Dickinson and Company | $18.74 | 2021 | |
| Kesin Pharma Corporation | $17.31 | 2023 | Likmez |
| Aspira Women'S Health INC | $10.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.